Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer.

The pharmacogenomics journal - 1 Feb 2021

Shiota Masaki, Narita Shintaro, Habuchi Tomonori, Eto Masatoshi

Abstract excerpt

Genetic polymorphism in YB-1 was previously shown to be associated with the prognosis of advanced prostate cancer patients treated with primary androgen-deprivation therapy. However, the significance of this polymorphism remains invalidated. In this study, we aimed to validate the prognostic significance of the YB-1 genetic polymorphism in metastatic prostate cancer. This study included 79 Japanese patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Prognosis

Share to Progression-Free Survival

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Share to Y-Box-Binding Protein 1

Source

Identifiers

PMID: 32963329
DOI: 10.1038/s41397-020-00188-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer.PMID 32963329Read ↗

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.Semantic proximity Read ↗

YB-1 variant and androgen receptor axis-targeted agents in metastatic castration-resistant prostate cancer patients.Semantic proximity Read ↗

Connecting Gene Variation to Treatment Outcomes in Metastatic Castration-Resistant Prostate Adenocarcinoma: Insights into Second-Generation Androgen Receptor Axis-Targeted Therapies.Semantic proximity Read ↗

Association of Missense Polymorphism inHSD3B1With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneSemantic proximity Read ↗

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.Semantic proximity Read ↗

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Semantic proximity Read ↗

[Clinical features and prognostic value of TP53 mutation in Chinese prostate cancer patients].Semantic proximity Read ↗

Genetic alterations of prostate cancer: in localized and metastatic prostate cancer.Semantic proximity Read ↗

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.Semantic proximity Read ↗

Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors.Semantic proximity Read ↗

Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer.Semantic proximity Read ↗

Genetic Contribution to Metastatic Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.